MeCP2 Drives Hepatocellular Carcinoma Progression Via Enforcing HOXD3 Promoter Methylation and Expression Through the HB-EGF/EGFR Pathway
- Type
- Retraction
- Notice date
- 6/5/2024 0:00
- Journal
- Molecular Oncology
- Publisher
- Wiley
- Notice DOI
- 10.1002/1878-0261.13681
- Original paper DOI
- 10.1002/1878-0261.13019
Reasons
- Duplication of/in Image
- Investigation by Journal/Publisher
- Investigation by Third Party
- Objections by Author(s)
- Unreliable Data
- Unreliable Results and/or Conclusions